These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 1973663)

  • 21. Binding characteristics of 3H-dihydroalprenolol to beta-adrenergic receptors of rat brain: influence of lectins.
    Tsuchihashi H; Nagatomo T
    Jpn J Pharmacol; 1985 Jun; 38(2):121-5. PubMed ID: 2993717
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Beta-adrenoceptors of human lymphocytes: decrease in affinity of agonist for (-)3h-dihydroalprenolol binding sites by cytoplasmic fractions.
    Watanabe Y; Lai RT; Higuchi H; Maeda H; Yoshida H
    Life Sci; 1981 Mar; 28(12):1399-405. PubMed ID: 6264246
    [No Abstract]   [Full Text] [Related]  

  • 23. Evaluation of 3H-CGP 12177 and 3H-DHA binding to beta 2-adrenoceptors of rat reticulocytes by means of affinity spectra.
    Kállay Z; Smisterová J; Soltés L; Marko V
    J Recept Res; 1991; 11(6):909-17. PubMed ID: 1661336
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phenylethanolaminotetralines compete with [3H]dihydroalprenolol binding to rat colon membranes without evidencing atypical beta-adrenergic sites.
    Landi M; Bianchetti A; Croci T; Manara L
    Biochem Pharmacol; 1992 Aug; 44(4):665-72. PubMed ID: 1354964
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of (-)-[3H]dihydroalprenolol binding to intact and broken cell preparations of human peripheral blood lymphocytes.
    Meurs H; van den Bogaard W; Kauffman HF; Bruynzeel PL
    Eur J Pharmacol; 1982 Nov; 85(2):185-94. PubMed ID: 6295780
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of three radioligands for the labelling of human beta-adrenoceptor subtypes.
    Niclauss N; Michel-Reher MB; Alewijnse AE; Michel MC
    Naunyn Schmiedebergs Arch Pharmacol; 2006 Nov; 374(2):99-105. PubMed ID: 17028849
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relationship between the (--)-[3H]-dihydroalprenolol binding to beta-adrenoceptors and transmembrane 86Rb efflux of the BC3H1 nonfusing muscle cell line.
    Mauger JP; Worcel M
    Br J Pharmacol; 1980 Apr; 68(4):731-9. PubMed ID: 6103725
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of monoclonal antibodies to the beta-adrenergic antagonist alprenolol as models of the receptor binding site.
    Sawutz DG; Sylvestre D; Homcy CJ
    J Immunol; 1985 Oct; 135(4):2713-8. PubMed ID: 2993414
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of 3H-dihydroalprenolol binding to beta-adrenergic receptors of rat brain: two binding sites of racemic propranolol in displacement experiments.
    Tsuchihashi H; Nagatomo T
    Chem Pharm Bull (Tokyo); 1987 Jul; 35(7):2979-84. PubMed ID: 2824078
    [No Abstract]   [Full Text] [Related]  

  • 30. Evidence for two specific affinity states of 3H-antagonist binding to cardiac beta-adrenergic receptors and influence of Gpp(NH)p.
    Lang PH; Lemmer B
    J Cyclic Nucleotide Protein Phosphor Res; 1985; 10(4):341-60. PubMed ID: 2993385
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [3H]dihydroalprenolol binding in the rat brainstem.
    Stone EA; U'Prichard DC
    Eur J Pharmacol; 1981 Oct; 75(2-3):159-61. PubMed ID: 6119217
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of putative beta-adrenoceptors in the myometrium of the pregnant ewe: correlation between the binding of [3H] dihydroalprenolol and the inhibition of myometrial contractility in vitro.
    Crankshaw DJ; Ruzycky AL
    Biol Reprod; 1984 Apr; 30(3):609-18. PubMed ID: 6144332
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Uptake of L-[propyl-2,3-3H]dihydroalprenolol by intact HeLa cells.
    Meier KE; Ruoho AE
    Biochim Biophys Acta; 1984 Jul; 804(3):331-40. PubMed ID: 6146352
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serotonin depletion unmasks serotonergic component of [3H]dihydroalprenolol binding in rat brain.
    Stockmeier CA; Kellar KJ
    Mol Pharmacol; 1989 Dec; 36(6):903-11. PubMed ID: 2557537
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pitfalls in the assessment of the specific binding of(-)[3H]-dihydroalprenolol to beta-adrenoceptors [proceedings].
    Nahorski SR; Richardson A
    Br J Pharmacol; 1979 Jul; 66(3):469P-470P. PubMed ID: 230879
    [No Abstract]   [Full Text] [Related]  

  • 36. Influence of polymeric effectors on binding of 3H-dihydroalprenolol to beta-adrenergic receptor of rat brain.
    Tsuchihashi H; Nagatomo T
    Jpn J Pharmacol; 1985 May; 38(1):17-23. PubMed ID: 2991640
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adrenergic receptor and catecholamine distribution in rat cerebral cortex: binding studies with [3H]prazosin, [3H]idazoxan and [3H]dihydroalprenolol.
    Diop L; Brière R; Grondin L; Reader TA
    Brain Res; 1987 Feb; 402(2):403-8. PubMed ID: 3828804
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Binding characteristics of [3H]dihydroalprenolol to beta-adrenergic receptors of rat brain: comparison with those of rat heart treated with neuraminidase.
    Tsuchihashi H; Sasaki M; Nagatomo T
    Chem Pharm Bull (Tokyo); 1985 Sep; 33(9):3972-6. PubMed ID: 3004753
    [No Abstract]   [Full Text] [Related]  

  • 39. Putative beta 4-adrenoceptors in rat ventricle mediate increases in contractile force and cell Ca2+: comparison with atrial receptors and relationship to (-)-[3H]-CGP 12177 binding.
    Sarsero D; Molenaar P; Kaumann AJ; Freestone NS
    Br J Pharmacol; 1999 Dec; 128(7):1445-60. PubMed ID: 10602323
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Binding characteristics of 3H-dihydroalprenolol to beta-adrenergic receptors of rat brain: influence of exo- and endo-glycosidases and glycopeptidase.
    Tsuchihashi H; Nagatomo T
    Jpn J Pharmacol; 1985 Aug; 38(4):403-9. PubMed ID: 2999487
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.